An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures

Detalhes bibliográficos
Autor(a) principal: Pereira, Renata C.
Data de Publicação: 2015
Outros Autores: Silva, Andrea N. M. R., Souza, Marta Cristina O., Silva, Marlon V., Neves, Patrícia P. C. C., Silva, Andrea A. M. V., Matos, Denise D. C. S., Herrera, Miguel A. O., Yamamura, Anna M. Y., Freire, Marcos S., Gaspar, Luciane P., Caride, Elena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/32037
Resumo: Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil
id CRUZ_55f901a9731dd717acb6cfd0767898ca
oai_identifier_str oai:www.arca.fiocruz.br:icict/32037
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Pereira, Renata C.Silva, Andrea N. M. R.Souza, Marta Cristina O.Silva, Marlon V.Neves, Patrícia P. C. C.Silva, Andrea A. M. V.Matos, Denise D. C. S.Herrera, Miguel A. O.Yamamura, Anna M. Y.Freire, Marcos S.Gaspar, Luciane P.Caride, Elena2019-03-12T13:33:41Z2019-03-12T13:33:41Z2015PEREIRA, Renata C. et al. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Vaccine, Amsterdam, v. 33, n. 35, p. 4261-4268, 2015.1873-2518https://www.arca.fiocruz.br/handle/icict/3203710.1016/j.vaccine.2015.03.077engAn inactivated yellow fever 17DD vaccine cultivated in Vero cell culturesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, BrasilYellow fever is an acute infectious disease caused by prototype virus of the genus Flavivirus. It is endemic in Africa and South America where it represents a serious public health problem causing epidemics of hemorrhagic fever with mortality rates ranging from 20% to 50%. There is no available antiviral therapy and vaccination is the primary method of disease control. Although the attenuated vaccines for yellow fever show safety and efficacy it became necessary to develop a new yellow fever vaccine due to the occurrence of rare serious adverse events, which include visceral and neurotropic diseases. The new inactivated vaccine should be safer and effective as the existing attenuated one. In the present study, the immunogenicity of an inactivated 17DD vaccine in C57BL/6 mice was evaluated. The yellow fever virus was produced by cultivation of Vero cells in bioreactors, inactivated with β-propiolactone, and adsorbed to aluminum hydroxide (alum). Mice were inoculated with inactivated 17DD vaccine containing alum adjuvant and followed by intracerebral challenge with 17DD virus. The results showed that animals receiving 3 doses of the inactivated vaccine (2 μg/dose) with alum adjuvant had neutralizing antibody titers above the cut-off of PRNT50 (Plaque Reduction Neutralization Test). In addition, animals immunized with inactivated vaccine showed survival rate of 100% after the challenge as well as animals immunized with commercial attenuated 17DD vaccine.Inactivated vaccineProtective responseYellow feverinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/32037/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINAL1-s2.0-S0264410X15003965-main.pdf1-s2.0-S0264410X15003965-main.pdfapplication/pdf957405https://www.arca.fiocruz.br/bitstream/icict/32037/2/1-s2.0-S0264410X15003965-main.pdf51e928d5e63ef04d9fda9967ba002bedMD52TEXT1-s2.0-S0264410X15003965-main.pdf.txt1-s2.0-S0264410X15003965-main.pdf.txtExtracted texttext/plain42258https://www.arca.fiocruz.br/bitstream/icict/32037/3/1-s2.0-S0264410X15003965-main.pdf.txtdae9029357737e137d5b18c9aa8b1f6dMD53icict/320372019-04-04 02:05:17.329oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-04-04T05:05:17Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
title An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
spellingShingle An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
Pereira, Renata C.
Inactivated vaccine
Protective response
Yellow fever
title_short An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
title_full An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
title_fullStr An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
title_full_unstemmed An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
title_sort An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
author Pereira, Renata C.
author_facet Pereira, Renata C.
Silva, Andrea N. M. R.
Souza, Marta Cristina O.
Silva, Marlon V.
Neves, Patrícia P. C. C.
Silva, Andrea A. M. V.
Matos, Denise D. C. S.
Herrera, Miguel A. O.
Yamamura, Anna M. Y.
Freire, Marcos S.
Gaspar, Luciane P.
Caride, Elena
author_role author
author2 Silva, Andrea N. M. R.
Souza, Marta Cristina O.
Silva, Marlon V.
Neves, Patrícia P. C. C.
Silva, Andrea A. M. V.
Matos, Denise D. C. S.
Herrera, Miguel A. O.
Yamamura, Anna M. Y.
Freire, Marcos S.
Gaspar, Luciane P.
Caride, Elena
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pereira, Renata C.
Silva, Andrea N. M. R.
Souza, Marta Cristina O.
Silva, Marlon V.
Neves, Patrícia P. C. C.
Silva, Andrea A. M. V.
Matos, Denise D. C. S.
Herrera, Miguel A. O.
Yamamura, Anna M. Y.
Freire, Marcos S.
Gaspar, Luciane P.
Caride, Elena
dc.subject.en.pt_BR.fl_str_mv Inactivated vaccine
Protective response
Yellow fever
topic Inactivated vaccine
Protective response
Yellow fever
description Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil
publishDate 2015
dc.date.issued.fl_str_mv 2015
dc.date.accessioned.fl_str_mv 2019-03-12T13:33:41Z
dc.date.available.fl_str_mv 2019-03-12T13:33:41Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv PEREIRA, Renata C. et al. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Vaccine, Amsterdam, v. 33, n. 35, p. 4261-4268, 2015.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/32037
dc.identifier.issn.pt_BR.fl_str_mv 1873-2518
dc.identifier.doi.none.fl_str_mv 10.1016/j.vaccine.2015.03.077
identifier_str_mv PEREIRA, Renata C. et al. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Vaccine, Amsterdam, v. 33, n. 35, p. 4261-4268, 2015.
1873-2518
10.1016/j.vaccine.2015.03.077
url https://www.arca.fiocruz.br/handle/icict/32037
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/32037/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/32037/2/1-s2.0-S0264410X15003965-main.pdf
https://www.arca.fiocruz.br/bitstream/icict/32037/3/1-s2.0-S0264410X15003965-main.pdf.txt
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
51e928d5e63ef04d9fda9967ba002bed
dae9029357737e137d5b18c9aa8b1f6d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008857817939968